p-Index From 2021 - 2026
11.301
P-Index
This Author published in this journals
All Journal HAYATI Journal of Biosciences Journal of Food and Pharmaceutical Science Indonesian Journal of Biotechnology MPI (Media Pharmaceutica Indonesiana) The Indonesian Biomedical Journal Science and Technology Indonesia Jurnal Akta Jurnal Fitofarmaka Indonesia DUNAMIS: Jurnal Teologi dan Pendidikan Kristiani Jurnal Pro Hukum : Jurnal Penelitian Bidang Hukum Universitas Gresik JFIOnline Jurnal Ilmu Kefarmasian Indonesia Jurnal Jamu Indonesia Journal of Social Science Jurnal Health Sains JURNAL RECTUM: Tinjauan Yuridis Penanganan Tindak Pidana Devotion: Journal of Research and Community Service Narra J International Journal of Social Service and Research Jurnal Impresi Indonesia International Journal of Science and Society (IJSOC) Indonesian Journal of Multidisciplinary Science Journal of Social Research Journal Of World Science MEDICINUS Journal of Law, Poliitic and Humanities Journal of Social Science The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy Return : Study of Management, Economic and Bussines INJURITY: Journal of Interdisciplinary Studies Journal Research of Social Science, Economics, and Management Eduvest - Journal of Universal Studies Jurnal Ekonomi, Teknologi dan Bisnis Journal of Social Science Influence: International Journal of Science Review Al Makki Health Informatics Journal Journal of Food and Pharmaceutical Sciences Journal of Law and Social Politics Asian Journal of Social and Humanities Indonesian Journal of Jamu Glosains: Jurnal Sains Global Indonesia
Claim Missing Document
Check
Articles

THE LEGAL PROTECTION OF PATENTS ON PHYTOPHARMACEUTICAL PRODUCTS IN INDONESIA: CASE STUDIES AND THEORETICAL PERSPECTIVES Tjandrawinata, Raymond R.; Budi, Henry Soelistyo
International Journal of Social Service and Research Vol. 4 No. 12 (2024): International Journal of Social Service and Research
Publisher : Ridwan Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46799/ijssr.v4i12.1160

Abstract

Indonesia has great potential in the development of biowealth-based phytopharmaceutical products, considering its rich natural wealth and traditional medicine traditions. This study uses theories of legal utilitarianism, distributive justice, and legal positivism to explore the challenges facing Indonesia, as well as opportunities for more inclusive and adaptive reforms. This analysis employs a normative juridical approach, focusing on the analysis of written laws, regulations, doctrines and legal interpretations related to patent protection for phytopharmaceutic products. This approach enables a thorough understanding of the patent legal framework in Indonesia and its practical implementation. The case study method is used to evaluate several patents registered with the Directorate General of Intellectual Property (DJKI). The results show that Indonesia is facing a number of complex legal challenges in the patent registration process, ranging from barriers to novelty criteria and inventive steps to lengthy administrative processes. In addition, Indonesia needs to strengthen its national patent system and intellectual property protection strategies to ensure that local communities benefit fairly from the use of their traditional knowledge. This research could investigate how these mechanisms influence innovation within local communities and their role in fostering sustainable practices.
Harmonization of International Patient Law in Biotechnology: Strategies For Enhancing Innovation And Global Access Raymond R. Tjandrawinata; Henry Soelistyo Budi
Journal of Law, Politic and Humanities Vol. 5 No. 2 (2024): (JLPH) Journal of Law, Politic and Humanities
Publisher : Dinasti Research

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.38035/jlph.v5i2.1146

Abstract

The fragmented global patent landscape poses significant challenges for biotechnology, one of the most innovative sectors of the 21st century. Despite the potential to revolutionize healthcare and agriculture, differences in patent regulation between jurisdictions impede progress, limit equitable access to therapies, and complicate international collaboration. This paper examines the key regulatory frameworks in the United States, the European Union, Japan, and China, focusing on the inherent strengths and challenges of each, by analyzing case studies, such as CRISPR gene editing and CAR-T therapy. The article identifies strategies to deal with ethical dilemmas, intellectual property rights differences, and cross-border enforcement issues. The analysis in this publication encourages harmonization initiatives through regional agreements, international dialogue, and open innovation models to promote global access and sustainable innovation.
Hand, foot, and mouth disease in children: forecasting of future research direction using bibliometric analysis Tan, Santi; Tjandrawinata, Raymond Rubianto
JURNAL ILMU KEFARMASIAN INDONESIA Vol 22 No 2 (2024): JIFI
Publisher : Faculty of Pharmacy, Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v22i2.1563

Abstract

Since 1997, hand, foot, and mouth disease (HFMD) has become a common health problem in Southeast Asia. Various types of research have been conducted and published to handle HFMD. However, until now, many children, especially in the Asia-Pacific region, including Indonesia, still have HFMD-causing enterovirus (EV) infection. By conducting a bibliometric analysis of the literature published over the last 27 years (1997–2024), the direction of HFMD research in children can be predicted, thus research areas that have the potential and still need to be developed for future better HFMD treatment can be known. The important HFMD research topics predicted to continue to develop were identified through keyword analysis, which was subsequently mapped using a network approach. Based on this study, it can be concluded that HFMD research is predicted to lead to the development of synbiotic supplements, which can reduce HFMD severity, especially in children, by utilizing a genome-wide association study (GWAS) and machine learning.
The Evolving Brain: Unraveling the Forces Shaping Human Cognition Raymond R. Tjandrawinata
Asian Journal of Social and Humanities Vol. 3 No. 4 (2025): Asian Journal of Social and Humanities
Publisher : Pelopor Publikasi Akademika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59888/ajosh.v3i4.475

Abstract

This interdisciplinary study explores the evolution of the human brain by integrating perspectives from anthropology, neuroscience, evolutionary biology, and technology studies. It delves into the factors driving brain expansion over time, including social complexity, dietary transitions, tool use, and the development of language. By synthesizing primary and secondary data, the research highlights the interplay between cognitive development and environmental pressures, showcasing how human neural architecture was shaped by adaptive responses to changing conditions. The findings reveal that evolutionary adaptations not only influenced brain size and structure but also laid the groundwork for cognitive resilience, particularly in the face of aging and modern technological advancements. This study underscores the profound impact of social and environmental challenges on brain evolution and its ongoing plasticity. Furthermore, it addresses critical questions about how rapid technological shifts are shaping cognitive functions and neural pathways today. By examining the past, present, and future trajectories of the human brain, this research provides a comprehensive framework for understanding its evolutionary processes and offers insights into navigating the challenges of an increasingly complex and technology-driven world.
Memanfaatkan Kecerdasan Buatan dan Pembelajaran Mesin dalam Inovasi Farmasi Raymond R. Tjandrawinata
MEDICINUS Vol. 38 No. 2 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/kma7ev64

Abstract

Integrasi kecerdasan buatan (artificial intelligence/AI) dan pembelajaran mesin (machine learning/ML) telah merevolusi industri farmasi, mengubah cara obat ditemukan, dikembangkan, diuji, dan diproduksi. Teknologi ini memungkinkan efisiensi dan akurasi yang belum pernah terjadi sebelumnya dengan memanfaatkan sejumlah besar data dan algoritmakomputasi canggih. Dalam penemuan obat, AI mempercepat identifikasi target terapeutik dan desain molekul baru, secara drastis mengurangi waktu menuju pemasaran. Selama pengembangan, ML membantu mengoptimalkan desain uji klinik dan stratifikasi populasi pasien untuk meningkatkan presisi dan efektivitas. Dalam uji klinik, alat berbasis AI meningkatkan rekrutmen, pemantauan, dan desain adaptif, menghasilkan studi yang lebih andal dan hemat biaya. Terakhir, AI memastikan pengendalian kualitas real-time dan pemeliharaan prediktif dalam manufaktur, meningkatkan konsistensi produk dan mengurangi biaya operasional. Makalah ini mengeksplorasi aplikasi AI/ML secara komprehensif di berbagai domain, didukung oleh studi kasus dan analisis mendalam tentang dampaknya. Selain itu, makalah ini membahas tantangan seperti kualitas data, hambatan regulasi, dan transparansi algoritma yang menghambat adopsinya secara luas. Pertimbangan etis, termasuk masalah privasi dan risiko bias dalam sistem AI juga dievaluasi. Akhirnya, makalah ini menguraikan peluang untuk kemajuan di masa depan, menekankan perlunya upaya kolaboratif antara akademisi, industri, dan badan regulasi untuk memanfaatkan potensi penuh AI/ML dalam membentuk kembali lanskap farmasi.
ADMINISTRATIVE DECISIONS IN THE PHARMACEUTICAL SECTOR: A COMPARATIVE ANALYSIS OF INDONESIA AND THE UNITED STATES Tjandrawinata, Raymond R.; Heliany, Ina
JURNAL RECTUM: Tinjauan Yuridis Penanganan Tindak Pidana Vol 7 No 1 (2025): EDISI BULAN JANUARI
Publisher : Lembaga Penelitian dan Pengabdian kepada Masyarakat (LPPM) Universitas Darma Agung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46930/jurnalrectum.v7i1.5349

Abstract

Administrative decisions in the pharmaceutical industry influence the balance between innovation protection and drug accessibility, particularly in developing countries like Indonesia. This study evaluates the impact of administrative decisions on Indonesia's pharmaceutical sector by comparing them with the policies of the United States Food and Drug Administration (FDA). The research employs a descriptive-qualitative approach, analyzing administrative law theory, Gustav Radbruch’s balance of law theory, intellectual property, and legal realism. The findings reveal that administrative decisions often reinforce patent protection, which promotes innovation but limits drug access, especially for low-income populations. In Indonesia, the National Agency of Drug and Food Control (BPOM) faces challenges in meeting public needs amidst limited adaptive regulations. Barriers to implementing compulsory licensing and international pressures complicate drug distribution arrangements, particularly in emergency situations. This study recommends harmonizing regulations with international standards, enhancing transparency in decision-making, and implementing compulsory licensing to address the tension between patent protection and accessibility. This approach is expected to create a more inclusive, equitable, and responsive pharmaceutical regulatory framework that meets societal needs without compromising innovation
Future Trends in Biotechnology Patents: Impact of Nano-Biomedicine and Artificial Intelligence on the Patent Landscape R. Tjandrawinata, Raymond; Soelistyo Budi, Henry
Journal of Law, Politic and Humanities Vol. 5 No. 3 (2025): (JLPH) Journal of Law, Politic and Humanities
Publisher : Dinasti Research

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.38035/jlph.v5i3.1205

Abstract

The development of nano-biomedicine and artificial intelligence (AI) technologies are changing the biotechnology landscape and the global patent system. Both technologies are advancing innovation in sectors such as oncology, genetic diseases, and vaccinology, while posing new challenges in the intellectual property legal framework. This article analyzes the specific sectors most affected by these technologies, discusses regulatory efforts in specific jurisdictions, as well as highlights patent-related case studies of major companies. Additionally, an analysis of the risks and opportunities for collaboration between various parties is outlined to demonstrate the need for regulatory reform to support global innovation. The article also provides strategic recommendations for policymakers as well as long-term projections on the impact of this technology on the patent system in the next 20-30 years.
Terapi Osteoporosis Terbaru: Tinjauan Komprehensif Farmakologis Raymond R. Tjandrawinata
MEDICINUS Vol. 38 No. 3 (2025): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.56951/d4enjy05

Abstract

Osteoporosis adalah penyakit metabolik tulang yang ditandai dengan penurunan massa dan gangguan mikroarsitektur tulang sehingga meningkatkan risiko fraktur. Pendekatan farmakologis terbaru mencakup agen antiresorptif seperti bisphosphonates dan denosumab, serta terapi anabolik seperti teriparatide dan romosozumab yang berperan dalammeningkatkan kepadatan mineral tulang. Selain pengobatan, suplementasi kalsium dan vitamin D serta modifikasi gaya hidup berperan dalam pencegahan dan pengelolaan osteoporosis. Pemantauan berkala terhadap kepadatan tulang dan efektivitas terapi diperlukan untuk menyesuaikan strategi pengobatan secara personalisasi dan meminimalkan efek samping. Dengan integrasi terapi berbasis biomarker, pendekatan multidisiplin dalam pengelolaan osteoporosis dapat semakin ditingkatkan untuk meningkatkan kualitas hidup pasien.
Docking Molekular dari Trigonella foenum-graceum sebagai Antidiabetes menggunakan Molegro Virtual Docking Prasetiyo, Andri; Mumpuni, Esti; Tjandrawinata, Raymond R
Jurnal Jamu Indonesia Vol. 4 No. 2 (2019): Jurnal Jamu Indonesia
Publisher : Tropical Biopharmaca Research Center, IPB University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29244/jji.v4i2.132

Abstract

Trigonella foenum-graceum atau fenugreek digunakan secara luas sebagai obat tradisional untuk pengobatan diabetes tetapi mekanisme kerjanya masih belum jelas. Penelitian bertujuan memprediksi senyawa dalam fenugreek yang berkhasiat sebagai antidiabetes secara in-silico dengan menggunakan perangkat lunak Molegro Virtual Docking . Docking dilakukan 10 Senyawa uji dalam fenugreek yaitu 4-hidroxyisoleucine, coumarine, diosgenin, galactomannan, isovitexin, quarcetin, tigogenin, trigoneline, vitexin dan yamogenin dengan 3 reseptor yaitu sugar beet alpha-glucosidase- (PDB ID : 3W37), human dipeptidyl peptidase-4 (PDB ID : 1X70), human peroxisome proliferator activated gamma (PDB: 2PRG) serta senyawa pembanding acarbose, sitagliptin dan rosiglitazone. Dari 10 senyawa uji, galactomanann memiliki nilai Rerank Score/RS paling rendah di dua reseptor yaitu alpha glucosidase dan peroxisome proliferator activated gamma dengan nilai berturut turut -116.56 kcal/mol dan -131.18 kcal/mol dan nilai RS acarbose -113.60 kcal/mol dan rosiglitazone -124.54 kcal/mol . Dari 10 senyawa uji, tigogenin memiliki nilai RS paling rendah direseptor dipeptidyl peptidase-4 dengan nilai RS -86.54 kcal/mol dan nilai RS sitagliptin -87.02 kcal/mol. Berdasarkan nilai RS, galactomannan diprediksi memiliki aktivitas antidiabetes yang bekerja pada reseptor alpha-glucosidase dan peroxisome proliferator activated gamma sedangkan tigogenin diprediksi memiliki aktivitas antidiabetes yang bekerja pada reseptor dipeptidyl peptidase-4.
Ethics and Intellectual Property Rights in Genetic Therapy Raymond R. Tjandrawinata; Ina Heliany; Henry Soelistyo Budi
Asian Journal of Social and Humanities Vol. 3 No. 5 (2025): Asian Journal of Social and Humanities
Publisher : Pelopor Publikasi Akademika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59888/ajosh.v3i5.500

Abstract

Genetic technology, particularly CRISPR-Cas9, has transformed the paradigm of treating genetic diseases by offering new hope for more effective and precise therapies. However, this advancement also presents significant ethical and intellectual property rights (IPR) challenges. This article explores the impact of patents on the development and accessibility of genetic therapy, as well as the ethical issues arising from human genetic modification, especially at the germline level. Using a qualitative analytical approach that combines literature reviews and case studies, the article examines patent disputes that have emerged in the development of CRISPR and how applied patent policies can exacerbate inequities in access to critically needed medical therapies. Furthermore, the article discusses ethical concerns regarding the misuse of genetic technology and its potential impact on future generations. In conclusion, the article proposes the need for more inclusive and balanced policies that prioritize both innovation and accessibility, as well as strict regulations to ensure the safe and ethical application of genetic technology, while considering broader social and cultural impacts.
Co-Authors . Anindyajati Achmad K. Harzif Agung Endro Nugroho Agung Endro Nugroho Andon Hestiantoro Andreas Bernadinus Atawolo Andri Prasetiyo Anindini Winda Amalia Anita Artarini Armini Syamsidi ARTARINI, ANITA Babu, Murali Mohan Budi Wiweko Caroline G. Puspita CATUR RIANI Citra Rosyidah Danang Agung Yunaidi Dayana, Hepy Debbie S. Retnoningrum Debbie S. Retroningrum DEBBIE SOEFIE RETNONINGRUM DERMAWAN, DONI Dewi Riskha Nurmalasari Diana Nur Afifah Esti Mumpuni Esti Mumpuni Esti, Esti Gayatri, Anggi Gita Pratama Hapsari, Riani Harry Martha Wijaya Hartati Tuna, Hartati Hee Jae Lee Heliany, Ina Henry Soelistyo Budi Henry Soelistyo Budi Henry Soelistyo Budi Henry Soelistyo Budi Henry Soelistyo Budi Henry Soelistyo Budi, Henry Soelistyo Herbert Situmorang Herbert Situmorang Hiendrawan, Stevanus Huda Shalahudin Darusman Ina Heliany Ina Heliany Ina Heliany Ina Heliany Ina Heliany Indriawati, Iin Irsan Hasan Ismaya, Wangsa T. Kaka Renaldi Kanadi Sumapradja Krisnayanti, Ni Putu Eka Kristiana, Hery Kristiana, Hery Laurentia Stephani Liana W. Susanto Lilik Sulastri Luh Putu Nurshanti, Ni Maggy T. Suhartono Maggy T. Suhartono Maggy Thenawidjaja Suhartono Marcellus Simadibrata K Martha Wijaya, Harry Melva Louisa Murali Mohan Babu Murdani Abdullah Nababan, Saut Horas Hatoguan Nafrialdi Nafrialdi Nailufar, Florensia Nailufar, Florensia Ni Luh Putu Nurshanti Novia Tri Astuti Novia Tri Astuti Novitasari, Putri Rachma Permanasari, Silmi Citra Prasetyo, Teguh Rachman, Andika Raden Muharam Natadisastra Retroningrum, Debbie S. Riani Hapsari Santi Tan Setiabudy, Rahajuningsih D Shirly Kumala SILMI MARIYA Simatupang, Stefeny Theresia Sinaga, Wenny S.L. Soelistyo Budi, Henry Steven Susanto, Liana W Suwijiyo Pramono Suwijiyo Pramono Tan, Santi Velliana Tanaya Viedya Novalinda Said Wahyunia Likhayati Septiana Wangsa T. Ismaya Wangsa Tirta Ismaya Wawaimuli Arozal Widjaja, Nadia Winoto, Imelda L Winoto, Imelda L Yanti, Yanti Zaelani, Bella Fatima Dora